Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Greene County Bancorp
GCBC
$402M
| $630K | ﹤0.01% |
21,946
| – | – |
|
2777
Groupon
GRPN
$912M
| $630K | ﹤0.01% |
73,414
-6,207
| -8% | -$53.3K |
|
2778
Northeast Bank
NBN
$947M
| $630K | ﹤0.01% |
14,974
-3,294
| -18% | -$139K |
|
2779
EverQuote
EVER
$872M
| $629K | ﹤0.01% |
42,645
-13,695
| -24% | -$202K |
|
|
ENFN
2780
DELISTED
Enfusion, Inc.
ENFN
| $626K | ﹤0.01% |
64,796
-4,359
| -6% | -$42.1K |
|
2781
iRadimed
IRMD
$913M
| $625K | ﹤0.01% |
22,114
-5,128
| -19% | -$145K |
|
|
BRT
2782
BRT Apartments
BRT
$286M
| $622K | ﹤0.01% |
31,682
-30,028
| -49% | -$590K |
|
2783
Veritone
VERI
$216M
| $621K | ﹤0.01% |
117,040
+35,477
| +43% | +$188K |
|
|
FINV
2784
FinVolution Group
FINV
$1.93B
| $615K | ﹤0.01% |
123,900
-36,800
| -23% | -$183K |
|
2785
Diageo
DEO
$58.1B
| $610K | ﹤0.01% |
3,424
+472
| +16% | +$84.1K |
|
2786
Preformed Line Products
PLPC
$957M
| $607K | ﹤0.01% |
7,288
-1,663
| -19% | -$139K |
|
2787
BARK
BARK
$148M
| $606K | ﹤0.01% |
407,057
-53,734
| -12% | -$80K |
|
2788
ESS Tech
GWH
$20.3M
| $605K | ﹤0.01% |
16,596
-260
| -2% | -$9.48K |
|
2789
First Western Financial
MYFW
$227M
| $604K | ﹤0.01% |
21,458
-10,318
| -32% | -$290K |
|
2790
Rackspace Technology
RXT
$345M
| $602K | ﹤0.01% |
204,071
-22,564
| -10% | -$66.6K |
|
|
KNTE
2791
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $602K | ﹤0.01% |
98,706
-12,347
| -11% | -$75.3K |
|
2792
ZimVie
ZIMV
$532M
| $598K | ﹤0.01% |
64,096
-40,603
| -39% | -$379K |
|
2793
Advantage Solutions
ADV
$606M
| $597K | ﹤0.01% |
286,879
-24,118
| -8% | -$50.2K |
|
2794
VistaGen Therapeutics
VTGN
$109M
| $597K | ﹤0.01% |
18,587
-1,136
| -6% | -$36.5K |
|
2795
Ocular Therapeutix
OCUL
$2.23B
| $594K | ﹤0.01% |
211,160
-46,102
| -18% | -$130K |
|
2796
Guaranty Bancshares
GNTY
$556M
| $590K | ﹤0.01% |
17,035
-8,372
| -33% | -$290K |
|
|
MAGN
2797
Magnera Corporation
MAGN
$413M
| $589K | ﹤0.01% |
11,775
-12,812
| -52% | -$641K |
|
2798
eGain
EGAN
$222M
| $587K | ﹤0.01% |
64,941
-7,968
| -11% | -$72K |
|
2799
Lifecore Biomedical
LFCR
$267M
| $586K | ﹤0.01% |
90,357
-13,508
| -13% | -$87.6K |
|
2800
Quantum-Si Incorporated
QSI
$227M
| $586K | ﹤0.01% |
320,303
-45,098
| -12% | -$82.5K |
|